Vitamin D, osteocalcin, and risk for adiposity as comorbidities in middle school children

Journal of Bone and Mineral Research

Volumn 27, Issue 2, 2012, Pages 283-293

  Boucher Berry, Claudia ^a   Speiser, Phyllis W ^a,b   Carey, Dennis E ^a,b   Shelov, Steven P ^a,b   Accacha, Siham ^c   Fennoy, Ilene ^d   Rapaport, Robert ^e   Espinal, Yomery ^d   Rosenbaum, Michael ^d  

^a Northwell Health   (United States)

^b HOFSTRA UNIVERSITY   (United States)

^c WINTHROP UNIVERSITY HOSPITAL   (United States)

^d NewYork Presbyterian Hospital   (United States)

^e MOUNT SINAI MEDICAL CENTER   (United States)

Author keywords

ADIPOSITY; INFLAMMATION; OSTEOCALCIN; TYPE 2 DIABETES MELLITUS; VITAMIN D

Indexed keywords

25 HYDROXYVITAMIN D; C REACTIVE PROTEIN; GLUCOSE; INSULIN; INTERLEUKIN 6; OSTEOCALCIN; PARATHYROID HORMONE; TUMOR NECROSIS FACTOR ALPHA; UNCARBOXYLATED OSTEOCALCIN; UNCLASSIFIED DRUG; VITAMIN D;

ADIPOSITY RELATED COMORBIDITY; ADOLESCENT; AFRICAN AMERICAN; ANTHROPOMETRY; ARTICLE; ASIAN; BODY COMPOSITION; CALCIUM METABOLISM; CHILD; COMORBIDITY; CONTROLLED STUDY; ETHNIC DIFFERENCE; FEMALE; GLUCOSE HOMEOSTASIS; GLUCOSE METABOLISM; HOMEOSTASIS; HUMAN; INFLAMMATION; INSULIN RESISTANCE; LIPID RISK SCORE; MAJOR CLINICAL STUDY; MALE; METABOLIC REGULATION; OBESITY; RACE DIFFERENCE; SCHOOL CHILD; SCORING SYSTEM; SOUTH ASIA; VITAMIN BLOOD LEVEL; VITAMIN D BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN D METABOLISM;

EID: 84856182295     PISSN: 08840431     EISSN: 15234681     Source Type: Journal    
DOI: 10.1002/jbmr.550     Document Type: Article

References (53)

1. Holick MF, Chen TC,. Vitamin D deficiency: a worldwide problem with health consequences. Am J Clin Nutr. 2008; 87: 1080S-6S. (Pubitemid 351549267)
2. Kumar J, Muntner P, Kaskel FJ, Hailpern SM, Melamed ML,. Prevalence and associations of 25-hydroxyvitamin D deficiency in US children: NHANES 2001-2004. Pediatrics. 2009; 124: e362-70.
3. Misra M, Pacaud D, Petryk A, Collett-Solberg PF, Kappy M,. Vitamin D deficiency in children and its management: review of current knowledge and recommendations. Pediatrics. 2008; 122: 398-417.
4. Ross AC, Manson JE, Abrams SA, Aloia JF, Brannon PM, Clinton SK, Durazo-Arvizu RA, Gallagher JC, Gallo RL, Jones G, Kovacs CS, Mayne ST, Rosen CJ, Shapses SA,. The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know. J Clin Endocrinol Metab. 2011; 96: 53-8.
5. Prentice A, Goldberg GR, Schoenmakers I,. Vitamin D across the lifecycle: physiology and biomarkers. Am J Clin Nutr. 2008; 88: 500S-6S.
6. Alemzadeh R, Kichler J, Babar G, Calhoun M,. Hypovitaminosis D in obese children and adolescents: relationship with adiposity, insulin sensitivity, ethnicity, and season. Metabolism. 2008; 57: 183-91.
7. Parikh SJ, Edelman M, Uwaifo GI, Freedman RJ, Semega-Janneh M, Reynolds J, Yanovski JA,. The relationship between obesity and serum 1,25-dihydroxy vitamin D concentrations in healthy adults. J Clin Endocrinol Metab. 2004; 89: 1196-9. (Pubitemid 38368412)
8. Tzotzas T, Papadopoulou FG, Tziomalos K, Karras S, Gastaris K, Perros P, Krassas GE,. Rising serum 25-hydroxy-vitamin D levels after weight loss in obese women correlate with improvement in insulin resistance. J Clin Endocrinol Metab. 2010; 95: 4251-7.
9. Zittermann A, Tenderich G, Koerfer R,. Vitamin D and the adaptive immune system with special emphasis to allergic reactions and allograft rejection. Inflamm Allergy Drug Targets. 2009; 8: 161-8.
10. Confavreux CB, Levine RL, Karsenty G,. A paradigm of integrative physiology, the crosstalk between bone and energy metabolisms. Mol Cell Endocrinol. 2009; 310: 21-9.
11. Ferron M, Hinoi E, Karsenty G, Ducy P,. Osteocalcin differentially regulates beta cell and adipocyte gene expression and affects the development of metabolic diseases in wild-type mice. Proc Natl Acad Sci U S A. 2008; 105: 5266-70. (Pubitemid 351738545)
12. Lee NK, Sowa H, Hinoi E, Ferron M, Ahn JD, Confavreux C, Dacquin R, Mee PJ, McKee MD, Jung DY, Zhang Z, Kim JK, Mauvais-Jarvis F, Ducy P, Karsenty G,. Endocrine regulation of energy metabolism by the skeleton. Cell. 2007; 130: 456-69. (Pubitemid 47208519)
13. Clemens TL, Karsenty G,. The osteoblast: an insulin target cell controlling glucose homeostasis. J Bone Miner Res. 2011; 26: 677-80.
14. Foresta C, Strapazzon G, De TL, Gianesello L, Calcagno A, Pilon C, Plebani M, Vettor R,. Evidence for osteocalcin production by adipose tissue and its role in human metabolism. J Clin Endocrinol Metab. 2010; 95: 3502-6.
15. Hwang YC, Jeong IK, Ahn KJ, Chung HY,. The uncarboxylated form of osteocalcin is associated with improved glucose tolerance and enhanced beta-cell function in middle-aged male subjects. Diabetes Metab Res Rev. 2009; 25: 768-72.
16. Hwang YC, Jeong IK, Ahn KJ, Chung HY,. Circulating osteocalcin level is associated with improved glucose tolerance, insulin secretion and sensitivity independent of the plasma adiponectin level. Osteoporos Int. [Epub ahead of print; PMID:21656264].
17. Pollock NK, Bernard PJ, Gower BA, Gundberg CM, Wenger K, Misra S, Bassali RW, Davis CL,. Lower uncarboxylated osteocalcin concentrations in children with prediabetes is associated with beta-cell function. J Clin Endocrinol Metab. 2011; 96: E1092-9.
18. Lian J, Stewart C, Puchacz E, Mackowiak S, Shalhoub V, Collart D, Zambetti G, Stein G,. Structure of the rat osteocalcin gene and regulation of vitamin D-dependent expression. Proc Natl Acad Sci U S A. 1989; 86: 1143-7. (Pubitemid 19061510)
19. O'Connor E, Molgaard C, Michaelsen KF, Jakobsen J, Cashman KD,. Vitamin D-vitamin K interaction: effect of vitamin D supplementation on serum percentage undercarboxylated osteocalcin, a sensitive measure of vitamin K status, in Danish girls. Br J Nutr. 2010; 104: 1091-5.
20. Ozaydin E, Dayangac-Erden D, Erdem-Yurter H, Derman O, Coskun T,. The relationship between vitamin D receptor gene polymorphisms and bone density, osteocalcin level and growth in adolescents. J Pediatr Endocrinol Metab. 2010; 23: 491-6.
21. Kamycheva E, Sundsfjord J, Jorde R,. Serum parathyroid hormone level is associated with body mass index. The 5th Tromso study. Eur J Endocrinol. 2004; 151: 167-72. (Pubitemid 39207010)
22. Reinehr T, de SG, Alexy U, Kersting M, Andler W,. Vitamin D status and parathyroid hormone in obese children before and after weight loss. Eur J Endocrinol. 2007; 157: 225-32. (Pubitemid 47233129)
23. Hill KM, McCabe GP, McCabe LD, Gordon CM, Abrams SA, Weaver CM,. An inflection point of serum 25-hydroxyvitamin D for maximal suppression of parathyroid hormone is not evident from multi-site pooled data in children and adolescents. J Nutr. 2010; 140: 1983-8.
24. Alvarez JA, Ashraf AP, Hunter GR, Gower BA,. Serum 25-hydroxyvitamin D and parathyroid hormone are independent determinants of whole-body insulin sensitivity in women and may contribute to lower insulin sensitivity in African Americans. Am J Clin Nutr. 2010; 92: 1344-9.
25. Rosenbaum M, Accacha SD, Altshuler LA, Carey DE, Fennoy I, Lowell BC, Rapaport R, Speiser PW, Shelov SP,. The Reduce Obesity and Diabetes (ROAD) project: design and methodological considerations. Child Obes. 2011; 7: 223-34.
26. Guiding principles for research involving animals and human beings. Am J Physiol Regul Integr Comp Physiol. 2002; 283: R281-3.
27. Dean AG, Arner TG, Sunki GG, Sangam S, Zubieta JC, Sullivan KM, Brendel KA, Gao Z, Fontaine N, Shu M, Fuller G, Smith DC, Nitschke DA, Fagan RF,. Epi Info (TM), a database and statistics program for public health professionals. Epi Info 3.4.3 Manual-Epi Info 2007, A Database, and Statistics Program for Public Health Professionals. Centers for Disease Control and Prevention (CDC) Atlanta, Georgia, USA.
28. Fernandez JR, Redden DT, Pietrobelli A, Allison DB,. Waist circumference percentiles in nationally representative samples of African-American, European-American, and Mexican-American children and adolescents. J Pediatr. 2004; 145: 439-44. (Pubitemid 39345977)
29. Cullen KW, Watson K, Zakeri I,. Relative reliability and validity of the Block Kids Questionnaire among youth aged 10 to 17 years. J Am Diet Assoc. 2008; 108: 862-6. (Pubitemid 351602053)
30. Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC,. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia. 1985; 28: 412-9. (Pubitemid 15018832)
31. Kahn SE,. The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes. Diabetologia. 2003; 46: 3-19. (Pubitemid 36237741)
32. Rosenbaum M, Nonas C, Horlick M, Fennoy I, Vargas I, Schachner H, Kringas P, Stanton K, Weil R,. beta-Cell function and insulin sensitivity in early adolescence: association with body fatness and family history of type 2 diabetes mellitus. J Clin Endocrinol Metab. 2004; 89: 5469-76. (Pubitemid 39523131)
33. Wilson PW, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB,. Prediction of coronary heart disease using risk factor categories. Circulation. 1998; 97: 1837-47. (Pubitemid 28213628)
34. Perneger TV,. What's wrong with Bonferroni adjustments. BMJ. 1998; 316: 1236-8. (Pubitemid 28171344)
35. Rothman KJ,. No adjustments are needed for multiple comparisons. Epidemiology. 1990; 1: 43-6. (Pubitemid 20255621)
36. Thomas DC, Siemiatycki J, Dewar R, Robins J, Goldberg M, Armstrong BG,. The problem of multiple inference in studies designed to generate hypotheses. Am J Epidemiol. 1985; 122: 1080-95. (Pubitemid 16170043)
37. Salamoun MM, Kizirian AS, Tannous RI, Nabulsi MM, Choucair MK, Deeb ME, El-Hajj Fuleihan GA,. Low calcium and vitamin D intake in healthy children and adolescents and their correlates. Eur J Clin Nutr. 2005; 59: 177-84. (Pubitemid 40268313)
38. Rauchenzauner M, Schmid A, Heinz-Erian P, Kapelari K, Falkensammer G, Griesmacher A, Finkenstedt G, Hogler W,. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years. J Clin Endocrinol Metab. 2007; 92: 443-9.
39. Zhou J, Zhao LJ, Watson P, Zhang Q, Lappe JM,. The effect of calcium and vitamin D supplementation on obesity in postmenopausal women: secondary analysis for a large-scale, placebo controlled, double-blind, 4-year longitudinal clinical trial. Nutr Metab (Lond). 2010; 7: 62.
40. Arabi A, El Rassi R, El-Hajj Fuleihan G,. Hypovitaminosis D in developing countries-prevalence, risk factors and outcomes. Nat Rev Endocrinol. 2010; 6: 550-61.
41. Rajakumar K, de Las HJ, Chen TC, Lee S, Holick MF, Arslanian SA,. Vitamin D status, adiposity, and lipids in black American and Caucasian children. J Clin Endocrinol Metab. 2011; 96: 1560-7.
42. Saleem U, Mosley TH Jr, Kullo IJ,. Serum osteocalcin is associated with measures of insulin resistance, adipokine levels, and the presence of metabolic syndrome. Arterioscler Thromb Vasc Biol. 2010; 30: 1474-8.
43. Reinehr T, Roth CL,. A new link between skeleton, obesity and insulin resistance: relationships between osteocalcin, leptin and insulin resistance in obese children before and after weight loss. Int J Obes (Lond). 2010; 34: 852-8.
44. Gracia-Marco L, Vicente-Rodriguez G, Valtuena J, Rey-Lopez JP, Diaz Martinez AE, Mesana MI, Widhalm K, Ruiz JR, Gonzalez-Gross M, Castillo MJ, Moreno LA,. Bone mass and bone metabolism markers during adolescence: The HELENA Study. Horm Res Paediatr. 2010; 74: 339-50.
45. Szulc P, Seeman E, Delmas PD,. Biochemical measurements of bone turnover in children and adolescents. Osteoporos Int. 2000; 11: 281-94. (Pubitemid 30417180)
46. Yoshimura N, Muraki S, Oka H, Kawaguchi H, Nakamura K, Akune T,. Biochemical markers of bone turnover as predictors of osteoporosis and osteoporotic fractures in men and women: 10-year follow-up of the Taiji cohort. Mod Rheumatol. [Epub ahead of print] DOI 10.1007/s10165-011-0455-2.
47. Pittas AG, Harris SS, Eliades M, Stark P, Dawson-Hughes B,. Association between serum osteocalcin and markers of metabolic phenotype. J Clin Endocrinol Metab. 2009; 94: 827-32.
48. Rosenbaum M, Nicolson M, Hirsch J, Heymsfield SB, Gallagher D, Chu F, Leibel RL,. Effects of gender, body composition, and menopause on plasma concentrations of leptin. J Clin Endocrinol Metab. 1996; 81: 3424-7. (Pubitemid 26296228)
49. Bikle D,. Nonclassic actions of vitamin D. J Clin Endocrinol Metab. 2009; 94: 26-34.
50. Pischon T, Girman CJ, Hotamisligil GS, Rifai N, Hu FB, Rimm EB,. Plasma adiponectin levels and risk of myocardial infarction in men. JAMA. 2004; 291: 1730-7. (Pubitemid 38489895)
51. Beauloye V, Zech F, Tran HT, Clapuyt P, Maes M, Brichard SM,. Determinants of early atherosclerosis in obese children and adolescents. J Clin Endocrinol Metab. 2007; 92: 3025-32. (Pubitemid 47236366)
52. Gravenstein KS, Napora JK, Short RG, Ramachandran R, Carlson OD, Metter EJ, Ferrucci L, Egan JM, Chia CW,. Cross-sectional evidence of a signaling pathway from bone homeostasis to glucose metabolism. J Clin Endocrinol Metab. 2011; 96: E884-90.
53. Iki M, Tamaki J, Fujita Y, Kouda K, Yura A, Kadowaki E, Sato Y, Moon JS, Tomioka K, Okamoto N, Kurumatani N,. Serum undercarboxylated osteocalcin levels are inversely associated with glycemic status and insulin resistance in an elderly Japanese male population: Fujiwara-kyo Osteoporosis Risk in Men (FORMEN) Study. Osteoporos Int. [Epub ahead of print; PMID: 21437719].